Eli Lilly and Company
News and overview for Eli Lilly and Company
LILLY (ELI) & COMPANY - Effient Recommendations in PCI-STEMI Guidelines [Press Release]
PRNewswire | 4 days 1 hour 54 minutes ago
Date: November 18, 2009 Refer to: Tammy Hull Eli Lilly and Company 317-651-9116 (office) 317-614-5132 (cell) Kimberly Wix Daiichi Sankyo (U.S.A.) 973-944-2338 (office) 908-656-5447 (cell) Shigemichi Kondo Daiichi Sankyo (Tokyo) 81-3-6225-1126 (office)
Eli Lilly eyes India, China for research
Financial Express (India), The | 3 days 5 hours 51 minutes ago
Lilly Singapore Centre for Drug Discovery, part of the $20-billion (FY2008 sales) Eli Lilly and Company, has said it could look at both India and China to partner with contract research organisations (CROs) in its efforts to discover new drugs in areas of cancer and metabolic disorders.
FDA update on BYETTA injection: Amylin Pharmaceuticals and Eli Lilly respond
News-Medical.Net | 19 days 17 hours ago
Amylin Pharmaceuticals, Inc., (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY) today issued the following statement in response to the U.S. Food and Drug Administration (FDA) update on BYETTA® (exenatide) injection.
LILLY (ELI) & COMPANY - STATEMENT ON FDA'S BYETTA (EXENATIDE) INJECTION UPDATE [Press Release]
PRNewswire | 19 days 13 hours 27 minutes ago
Media contacts: Amylin - Anne Erickson
LILLY (ELI) & COMPANY - BYETTA Apprd Expand Use 1st-Line Trtmnt Type 2 Diabetes [Press Release]
PRNewswire | 20 days 7 hours 16 minutes ago
Media contacts: Amylin - Anne Erickson
Eli Lilly selects ICON to provide clinical data management outside the US
News-Medical.Net | 20 days 17 hours 12 minutes ago
ICON plc, (NASDAQ:ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has signed an extension to its strategic agreement with Eli Lilly and Company (NYSE:LLY) to manage the companys clinical data management outside the US
Lilly Surpasses United Way 2009 Campaign Goal [Press Release]
PRNewswire | 6 days 7 hours 27 minutes ago
INDIANAPOLIS, Nov. 16 /PRNewswire-FirstCall/ -- Eli Lilly and Company
LILLY (ELI) & COMPANY - Lilly to Sell Tippecanoe Mnfctg Site to Evonik Ind [Press Release]
PRNewswire | 39 days 8 hours 5 minutes ago
Date: October 14, 2009
LILLY (ELI) & COMPANY - Research Update [Press Release]
PRNewswire | 6 days 7 hours 1 minute ago
Date: Nov. 15, 2009 Refer to: Derin Denham Eli Lilly and Company +1-317-277-6749 (office) +1-317-370-1435 (cell) Dr. Michaela Paudler-Debus Daiichi Sankyo Europe GmbH +49-(0)89-78 08 685 (office) +49-(0)172-845 8974 (cell) Shigemichi Kondo Daiichi Sankyo (Tokyo) 81-3-6225-1126 (office)
LILLY (ELI) & COMPANY - USDC Upholds Validity Lilly's Evista Patents To 2014 [Press Release]
PRNewswire | 59 days 13 hours 54 minutes ago
Date: September 23, 2009
LILLY (ELI) & COMPANY - Lilly Blueprint Speed Innovative Meds to Patients [Press Release]
PRNewswire | 69 days 12 hours 25 minutes ago
Date: September 14, 2009
Eli Lilly receives access to GeneNews' osteoarthritis genomic biomarker program
News-Medical.Net | 26 days 14 hours 7 minutes ago
GeneNews Limited (TSX: GEN), a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today announced that it has entered into an agreement allowing Eli Lilly and Company (NYSE: LLY) select access to research from its osteoarthritis genomic biomarker program. Terms of the agreement were not disclosed.
Eli Lilly and Company Opens Eco-Friendly Biotechnology Center on the West Coast Designed to Speed and Enhance Innovation [Press Release]
PRNewswire | 24 days 1 hour 42 minutes ago
SAN DIEGO, Oct. 29 /PRNewswire-FirstCall/ -- As part of its strategy to discover and develop more biotechnology medicines, Eli Lilly and Company today officially opened a new state-of-the-art biotechnology center on the West Coast. The facility, known as the "Lilly Biotechnology Center - San Diego," is opening three months after Lilly announced it is moving its ImClone research headquarters (which specializes in developing cancer biologics) into a new biopharmaceutical research cluster in Ne...
Amylin Pharmaceuticals and Eli Lilly and Company Statement on FDA's BYETTA(R) (Exenatide) Injection Update [Press Release]
PRNewswire | 19 days 23 hours 57 minutes ago
Amylin Pharmaceuticals and Eli Lilly and Company Statement on FDA's BYETTA(R) (Exenatide...FirstCall/ -- Amylin Pharmaceuticals, Inc., and Eli Lilly and Company today issued the following statement in response...
LILLY (ELI) & COMPANY - CORRECTION New Data Patients W Chr LBP Cymbalta [Press Release]
PRNewswire | 72 days 9 hours 55 minutes ago
For Release: 11 September 2009
Sign up for BIO SmartBrief
Company Overview
| Company: | Eli Lilly and Company |
|---|---|
| Industry: | Pharmaceuticals Manufacturers |
| Website: | http://www.lilly.com |
Eli Lilly hopes everything will come up roses for you, healthwise. Although best known for its popular antidepressant Prozac, the company develops medicines for a wide variety of ailments. Its top drugs include neurological therapies Zyprexa (schizophrenia and bipolar disorder) and Cymbalta (depression), cancer treatments Gemzar and Alimta, and endocrinology (hormone-related) products such as Humalog insulin and osteoporosis medication Evista. The company also makes cardiovascular therapies and anti-infective agents, as well as animal health products. Eli Lilly sells its products in some 135 countries.
Key Numbers
| Sales in U.S. Dollars (mil.) | 20,378 (2008) |
|---|---|
| One-year % Growth in Sales | 9.4 (2008) |
| Net Income in U.S. Dollars (mil.) | -2,071.9 (2008) |
| One-year % Growth in Net Income | 0.0 (2008) |
| Number of Employees | 40,500 (2008) |
| One-year % Growth in Number of Employees | -0.2 (2008) |
| Fiscal Year-End | December |